Stockscreener 앱 받기
13.52
0.22%
0.03
시간 외 거래:
13.53
0.010
+0.07%
Organon Co 주식(OGN)의 최신 뉴스
OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal - Stocktwits
Sun Pharma to Acquire Organon in US$11.75 Billion Deal, Strengthening Global Healthcare Portfolio - eHealth Magazine
Organon (OGN) Q1 2026 earnings summary - Quartr
Price-Driven Insight from (OGN) for Rule-Based Strategy - Stock Traders Daily
Organon (OGN) Proxy filing Summary - Quartr
SBI Joins 10 Global Lenders in Sun Pharma's Organon Financing Deal - outlookbusiness.com
SBI joins global banks to fund Sun's Organon buy - Magzter
What Sparked Organon's Recent Stock Surge - Kavout | AI
Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada - AOL.com
SBI joins global banks to fund Sun Pharma's $11.75 billion Organon buy - Business Standard
Organon to present VTAMA cream data at pediatric dermatology meeting - Investing.com
Organon to present VTAMA cream data at pediatric dermatology meeting By Investing.com - Investing.com Nigeria
Organon’s VTAMA data heads to pediatric dermatology meeting - Stock Titan
Sun Pharma's $11.8 bn Organon buy drives India's M&A value to 4-year high - Business Standard
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance
OGNOrganon & Co Volatility & Greeks - Finviz
OGN Q1 2026 Earnings: EPS Misses Estimates Amidst Operational ChallengesShare Repurchase Impact - dars.gov.et
Can Organon & Co. (OGN)’s MIUDELLA Launch Become a Major Driver in Women’s Health Markets? - Insider Monkey
Organon & Co. Actuals & Estimates (NYSE:OGN) - TradingView
Organon & Co updates strategic focus, shares watched on NYSE - AD HOC NEWS
Organon wins FDA nod to expand TOFIDENCE use in severe CRS & COVID-19 - MSN
Class Action Lawsuit Filed: Organon & Co. (OGN)Join by July 22, 2025Contact Levi & Korsinsky - The National Law Review
Enterprise value to EBITDA forward of Organon & Co. – MUN:7XP - TradingView
Price to earnings forward of Organon & Co. – NYSE:OGN - TradingView
Price to earnings forward of Organon & Co. – LSE:0A9W - TradingView
Organon and Henlius launch Prolia and Xgeva biosimilars in Canada - MSN
Mayne Pharma appoints former Organon & Co executive Meghan Rivera to board - MSN
(OGN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Price to sales forward of Organon & Co. – NYSE:OGN - TradingView
Enterprise value to EBITDA forward of Organon & Co. – LSE:0A9W - TradingView
Enterprise value to revenue forward of Organon & Co. – NYSE:OGN - TradingView
Shareholders of Organon & Co. (OGN): Protect Your Rights Before July 22, 2025Contact Levi & Korsinsky - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Organon & Co. (OGN) And Encourages Stockholders to Connect - The National Law Review
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Organon & Co. (OGN) Investors of July 22, 2025 Deadline - The National Law Review
Levi & Korsinsky Notifies Organon & Co. (OGN) InvestorsLead Plaintiff Deadline on July 22, 2025 - The National Law Review
OGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
FINAL OGN DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Org - The National Law Review
Recover Investment Losses: Levi & Korsinsky Files Class Action Against Organon & Co. (OGN) - The National Law Review
Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025Contact Levi & Korsinsky - The National Law Review
Securities Fraud Class Action Filed Against Organon & Co. (OGN) - The National Law Review
Enterprise value to EBIT forward of Organon & Co. – LSE:0A9W - TradingView
Organon & Co updates earnings timing, shares watched by health care investors - Ad-hoc-news.de
Organon celebrates 5 years of expanding healthcare access - Manila Standard
Organon & Co (OGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Organon & Co stock hits 52-week high at $13.49 - Investing.com UK
Organon & Co stock hits 52-week high at $13.49 By Investing.com - Investing.com Nigeria
Sun Pharma to acquire US-based Organon in nearly $11.75 billion deal - DD News
Are TBRG, OGN, MDV Obtaining Fair Deals for their Shareholders? - TradingView
OGN Forecast — Price Target — Prediction for 2027 - TradingView
Gorvins supports Organon Trustees through acquisition process - Marketing Stockport
Organon & Co (OGN) Institutional Confidence - TradingKey
Samsung Bioepis and Organon Expand Canadian Biosimilars Alliance with PYZCHIVA® Commercialisation Agreement - BioPharma APAC
Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co.OGN - Business Wire
0.33%
1.23%
자본화:
|
볼륨(24시간):